Form 4 for HOWL Werewolf Therapeutics, Inc.
Accepted 2022-01-04 00:00:00 ET · period of report 2021-12-30 · accession 0000899243-22-000510 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-01-04 | 2021-12-30 | HOWL | Leonard Reid | COO | M - OptEx | $1.56 | +14.1K | 14.1K | New | +$22.0K |
| D | 2022-01-04 | 2021-12-30 | HOWL | Leonard Reid | COO | M - OptEx | $0.00 | -14.1K | 47.0K | -23% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-12-30 | M | A | 14,102 | $1.56 | 14,102 | D | — | — | |
| 2 | Derivative | Stock Option (Right to Buy) | 2021-12-30 | M | D | 14,102 | $0.00 | 47,034 | D | $1.56 · — to 2030-05-19 | 14,102 Common Stock | (F1) The option was granted on May 20, 2020 with a Vesting Commencement Date of June 1, 2020. The shares underlying the option vest over four years, with 25% of the shares vesting on the first anniversary of the Vesting Commencement Date and 2.0833% of the shares vesting each month thereafter through June 1, 2024. |